David R. Bauer
Lawyers
Filters
NeoGenomics $316.25 million convertible senior notes offering
We advised the initial purchasers on the offering
SOPHiA GENETICS $57.5 million follow-on offering
We advised SOPHiA GENETICS on the offering
PTC Therapeutics $550 million convertible senior notes offering
We advised the initial purchasers on the offering
TARGAN sale to Merck Animal Health
We are advising TARGAN on the transaction
IDEAYA Biosciences $345 million equity offering
We advised the joint book-running managers and underwriters on the offering
GSK $10.6 billion acquisition of Nuvalent
We are advising GSK on the transaction
Inventiva $120 million underwritten offering
We advised the underwriters on the offering
Sumitomo Pharma ¥102.1 billion stock offering
We advised the joint lead managers and joint bookrunners on the offering
Roche acquisition of SAGA Diagnostics
We advised Roche on the transaction
Editas Medicine $125 million follow-on offering
We advised the joint book-running managers on the offering